![Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.](https://larvolclin.s3.us-west-2.amazonaws.com/resize_167102267117329064566399c84f2b28e.jpg)
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/1164/1*Ez9wN00qAPfVXWxdQp_Zfg.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/738/1*OW9WSYQzfS0YPsmRFQe0Tg.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/1156/1*qPRCcQmdolHNitdKERHf0A.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.](https://larvolclin.s3.us-west-2.amazonaws.com/resize_16710226757400194226399c85310f42.jpg)
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/670/1*XaZWoqTlQjGaRQqiwRemgA.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.](https://larvolclin.s3.us-west-2.amazonaws.com/resize_167102165914057112496399c45beaaeb.jpg)
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/940/1*uvR11Ya6ONLhtF2PNW168A.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/1144/1*IGebGBmrjmTtG0byozxu9Q.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/1358/1*6ePLqv7XBZDq0IyOkBf_qw.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/1194/1*mimACEKqINuEDmyXBFvRxw.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium](https://miro.medium.com/max/556/1*jgJFOxcAuSy6_3Wxk3-3GA.png)
Cohen's Kappa and Fleiss' Kappa— How to Measure the Agreement Between Raters | by Audhi Aprilliant | Medium
![Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.](https://larvolclin.s3.us-west-2.amazonaws.com/resize_16710226033379217566399c80bbf928.jpg)